Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kung

Showing results (251-260 of 378) with videos related to

Pageof 38
Sort By:
Blood|April 3, 2015
Identification of novel therapeutic targets in acute leukemias with NRAS mutations using a pharmacologic approachAtsushi Nonami, Martin Sattler, Ellen Weisberg, et al.
Molecular Cancer Therapeutics|January 17, 2012
Molecular and cellular effects of NEDD8-activating enzyme inhibition in myelomaDouglas W McMillin, Hannah M Jacobs, Jake E Delmore, et al.
Blood|October 28, 2006
Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemiasEllen Weisberg, Laurie Catley, Renee D Wright, et al.
Genes & Cancer|December 25, 2012
The STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 MutationsErik A Nelson, Sarah R Walker, Michael Xiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic LeukemiaYana Pikman, Gabriela Alexe, Giovanni Roti, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 27, 2024
Donor-derived posttransplant lymphoproliferative disease detection by donor-derived cell-free DNAMia Wungnema, Madelaine Hack, Evgeniya Vaskova, et al.
British Journal of Haematology|February 5, 2013
KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemiaJulia Etchin, Takaomi Sanda, Marc R Mansour, et al.
Molecular Cancer Therapeutics|September 3, 2010
Discovery and characterization of novel mutant FLT3 kinase inhibitorsEllen Weisberg, Hwan Geun Choi, Rosemary Barrett, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapyYaniv Kazansky, Daniel Cameron, Helen S Mueller, et al.
Neuro-Oncology|November 5, 2014
Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastomaAdam L Green, Shakti H Ramkissoon, Dilara McCauley, et al.
Pageof 38

Showing results (251-260 of 378) with videos related to

Sort By:
Pageof 38
Blood|April 3, 2015
Identification of novel therapeutic targets in acute leukemias with NRAS mutations using a pharmacologic approachAtsushi Nonami, Martin Sattler, Ellen Weisberg, et al.
Molecular Cancer Therapeutics|January 17, 2012
Molecular and cellular effects of NEDD8-activating enzyme inhibition in myelomaDouglas W McMillin, Hannah M Jacobs, Jake E Delmore, et al.
Blood|October 28, 2006
Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemiasEllen Weisberg, Laurie Catley, Renee D Wright, et al.
Genes & Cancer|December 25, 2012
The STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 MutationsErik A Nelson, Sarah R Walker, Michael Xiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic LeukemiaYana Pikman, Gabriela Alexe, Giovanni Roti, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 27, 2024
Donor-derived posttransplant lymphoproliferative disease detection by donor-derived cell-free DNAMia Wungnema, Madelaine Hack, Evgeniya Vaskova, et al.
British Journal of Haematology|February 5, 2013
KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemiaJulia Etchin, Takaomi Sanda, Marc R Mansour, et al.
Molecular Cancer Therapeutics|September 3, 2010
Discovery and characterization of novel mutant FLT3 kinase inhibitorsEllen Weisberg, Hwan Geun Choi, Rosemary Barrett, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapyYaniv Kazansky, Daniel Cameron, Helen S Mueller, et al.
Neuro-Oncology|November 5, 2014
Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastomaAdam L Green, Shakti H Ramkissoon, Dilara McCauley, et al.
Pageof 38